PortfoliosLab logo

iShares Nasdaq Biotechnology ETF

IBB
ETF · Currency in USD
ISIN
US4642875565
CUSIP
464287556
Issuer
iShares
Inception Date
Feb 5, 2001
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.47%
Index Tracked
NASDAQ Biotechnology Index
ETF Home Page
www.ishares.com
Asset Class
Equity
Asset Class Size
Multi-Cap
Asset Class Style
Growth

IBBPrice Chart


Click Calculate to get results
S&P 500

IBBPerformance

The chart shows the growth of $10,000 invested in iShares Nasdaq Biotechnology ETF on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $55,457 for a total return of roughly 454.57%. All prices are adjusted for splits and dividends.


IBB (iShares Nasdaq Biotechnology ETF)
Benchmark (S&P 500)

IBBReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M0.66%
YTD-1.09%
6M8.83%
1Y16.91%
5Y11.49%
10Y15.43%

IBBMonthly Returns Heatmap


Click Calculate to get results

IBBSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current iShares Nasdaq Biotechnology ETF Sharpe ratio is 0.73. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


IBB (iShares Nasdaq Biotechnology ETF)
Benchmark (S&P 500)

IBBDividends

iShares Nasdaq Biotechnology ETF granted a 0.26% dividend yield in the last twelve months, as of May 9, 2021. The annual payout for that period amounted to $0.39 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.39$0.31$0.21$0.19$0.32$0.16$0.03$0.15$0.02$0.22$0.00$0.17
Dividend yield
0.26%0.20%0.17%0.19%0.30%0.19%0.03%0.15%0.03%0.48%0.01%0.55%

IBBDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


IBB (iShares Nasdaq Biotechnology ETF)
Benchmark (S&P 500)

IBBWorst Drawdowns

The table below shows the maximum drawdowns of the iShares Nasdaq Biotechnology ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the iShares Nasdaq Biotechnology ETF is 39.24%, recorded on Jun 27, 2016. It took 974 trading sessions for the portfolio to recover.


Depth
Start
To Bottom
Bottom
To Recover
End
Total
-39.24%Jul 21, 2015237Jun 27, 2016974May 11, 20201211
-22.66%Jul 11, 201121Aug 8, 2011107Jan 10, 2012128
-21.18%Feb 26, 201434Apr 14, 201493Aug 26, 2014127
-18.94%Mar 24, 201072Jul 6, 2010115Dec 16, 2010187
-15.05%Feb 9, 202143Apr 12, 2021
-12.98%Jul 21, 202035Sep 8, 202061Dec 3, 202096
-12.75%Oct 8, 201222Nov 8, 201257Feb 1, 201379
-9.81%May 15, 201326Jun 20, 201314Jul 11, 201340
-9.25%Apr 24, 20155Apr 30, 201529Jun 11, 201534
-9.02%Oct 2, 20136Oct 9, 201331Nov 21, 201337

IBBVolatility Chart

Current iShares Nasdaq Biotechnology ETF volatility is 16.42%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


IBB (iShares Nasdaq Biotechnology ETF)
Benchmark (S&P 500)

Portfolios with iShares Nasdaq Biotechnology ETF


Loading data...

More Tools for iShares Nasdaq Biotechnology ETF